Cooper Creek Partners Management LLC Oyster Point Pharma, Inc. Transaction History

Cooper Creek Partners Management LLC

  • $3.64 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$8.58 - $17.65 $682,195 - $1.4 Million
-79,510 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$11.67 - $18.07 $113,082 - $175,098
-9,690 Reduced 10.86%
79,510 $942,000
Q2 2020

Aug 13, 2020
BUY
$27.86 - $35.93 $2.49 Million - $3.2 Million
89,200 New
89,200 $2.58 Million

Others Institutions Holding OYST

# of Institutions
4
Shares Held
19K
Call Options Held
0
Put Options Held
0
View Full List

About Oyster Point Pharma, Inc.

OYST Quotes by TradingView
  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Cooper Creek Partners Management LLC Portfolio

Follow Cooper Creek Partners Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper Creek Partners Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cooper Creek Partners Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email